Delivra’s current pharmaceutical offerings as per page 7 of their investor slide deck.
Delivra’s current pharmaceutical offerings as per page 7 of their investor slide deck.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.